WASHINGTON — Two Democratic lawmakers are pressing major pharmaceutical companies to explain their pricing strategies for multiple sclerosis drugs.

Reps. Elijah Cummings of Maryland and Peter Welch of Vermont wrote to Bayer (BAYN), Biogen (BIIB), EMD Serono, Novartis (NVS), Sanofi (SNY), Teva, and Roche Pharmaceuticals (ROG) to request documents that reference pricing strategies. They also asked for information about corporate profits, expenses, patient assistance programs, and drug distribution systems.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

X